Atlas Trials

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

Clinical trial NCT02532712 · COMPLETED

Trial details

NCT number
NCT02532712
Sponsor
Enzychem Lifesciences Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chemotherapy-Induced Neutropenia
Start date
2015-03-01
Primary completion
2015-12-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.